BioSpace News Archive

The American Diabetes Association welcomes the 2020 Principal Officers and Board of Directors.

NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’) today announced its global development strategy for 2020 and beyond, following proof-of-concept (POC) and European market approval for NBTXR3 in locally advanced soft tissue sarcoma of the extremities and trunk wall (Brand Name: Hensify®) in 2019.

Dr. Schindler is an internationally recognized expert with 18 years of experience in the treatment of acute stroke and other vascular conditions of the brain and spine.

Franciosi Consulting Ltd. is pleased to announce that it has been retained by Vicenna Pharmaceuticals Inc., a new private drug discovery company in Vancouver, British Columbia, to assist with its new research addressing the unmet needs of patients with asthma and Chronic Obstructive Pulmonary Disease.

ICU Medical, Inc. announced that Company management will present at the J.P. Morgan 38th Annual Healthcare Conference, held on January 13-16, 2020 in San Francisco, CA.

Quotient Limited announced the planned appointment of Peter Buhler as Chief Financial Officer replacing Chris Lindop, the current CFO who plans to retire in May 2020.

Amgen will present via video conference at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference at 1 p.m. PT on Thursday, Jan. 9, 2020.

SeaSpine Holdings Corporation announced preliminary financial results for the fourth quarter and full-year 2019, with U.S Spinal Implants revenues expected to reflect growth within the 20% to 21% range.

Tilray, Inc. announced that Brendan Kennedy, President and Chief Executive Officer, will present at the 2020 ICR Conference.

CooperCompanies, announced that that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 10, 2020, to stockholders of record on January 23, 2020.